10 Nov PLI Scheme for Medical Devices: New Applications Invited
✎ The Production-Linked Incentive (PLI) Scheme for Medical Devices is a government initiative to boost domestic manufacturing of medical devices and their critical components, extended until 2035-36 with simplified provisions to…
Subject Relevance — Where This Topic Fits
- GS Paper II — Government Policies and Interventions for Development in various sectors and Issues arising out of their Design and Implementation | GS Paper III — Indian Economy and issues relating to Planning, Mobilization of Resources, Growth, Development and Employment; Industrial Policy
- Prelims: Production-Linked Incentive (PLI) Scheme, Medical Devices Manufacturing, Department of Pharmaceuticals, Ease of Doing Business, Make in India, Aatmanirbhar Bharat, Target Segments for Medical Devices
- Essay: The role of government policies in fostering domestic manufacturing and achieving self-reliance., Economic growth and employment generation through targeted industrial incentives.
Quick Revision: The Production-Linked Incentive (PLI) Scheme for Medical Devices is a government initiative to boost domestic manufacturing of medical devices and their critical components, extended until 2035-36 with simplified provisions to enhance ease of doing business and promote self-reliance.
Why is this in the news?
The Government of India has invited new applications under the Production-Linked Incentive (PLI) Scheme for Medical Devices, extending its duration until 2035-36. This initiative aims to further boost domestic manufacturing of high-value medical devices and their critical components, with an outlay of approximately ₹2,700 crore. The scheme’s provisions have been simplified to enhance ease of doing business, including the removal of minimum sales conditions for incentives and a reduction in minimum investment requirements.
Background
- The PLI Scheme for Medical Devices was initially launched in 2021-22 with the objective of promoting domestic manufacturing and reducing import dependence in the medical device sector.
- Since its inception, the scheme has facilitated the domestic production of over 60 high-end medical devices and components, including advanced imaging equipment and critical implants.
- The medical device sector is crucial for healthcare infrastructure, and domestic manufacturing contributes to affordability, accessibility, and quality of healthcare services.
- India’s medical device market is one of the fastest-growing globally, yet it heavily relies on imports for high-end products, necessitating policy interventions to strengthen indigenous capabilities.
- The ‘Make in India’ and ‘Aatmanirbhar Bharat’ initiatives underscore the government’s commitment to fostering self-reliance across critical sectors, including medical devices.
Production-Linked Incentive (PLI) Scheme for Medical Devices
- The PLI Scheme for Medical Devices is a central sector scheme administered by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
- It offers financial incentives to eligible manufacturers based on incremental sales of domestically manufactured goods over a base year, encouraging large-scale production.
- The scheme has been extended until 2035-36 with an outlay of approximately ₹2,700 crore, reflecting a long-term commitment to the sector’s growth.
- Applicants can establish manufacturing units in four targeted segments: medical consumables/disposables/implants (TS-1), critical components (TS-2), high-end medical devices with nascent domestic manufacturing (TS-3), and high-end medical devices currently only assembled in India (TS-4).
- Incentive rates vary by segment, averaging around 5% for TS-1, 9% for TS-2 and TS-3, and 6% for TS-4, designed to promote value chain integration and competitiveness.
- Key amendments include the removal of minimum sales conditions for incentive eligibility and a reduction in minimum investment requirements, making the scheme more accessible to a wider range of investors.
- The scheme prioritizes the manufacturing of critical components to enhance value chain integration and support Micro, Small, and Medium Enterprises (MSMEs).
- It aims to attract investment, create employment opportunities, improve the quality of Indian-made medical devices, reduce prices, and enhance India’s global competitiveness in high-tech medical technology.
Key Features
| Feature | Significance |
|---|---|
| Scheme Extension | Extended until 2035-36, providing long-term policy certainty for investment and manufacturing planning in the medical devices sector. |
| Enhanced Outlay | Approximately ₹2,700 crore allocated to bolster domestic manufacturing, indicating substantial governmental commitment to the sector. |
| Simplified Eligibility | Minimum sales condition removed and minimum investment requirement reduced, aiming to broaden participation, especially for MSMEs. |
| Investor-Friendly Guidelines | Streamlined provisions to improve ease of doing business, attracting greater domestic and foreign investment. |
| Targeted Segments | Four distinct segments (TS-1 to TS-4) with varying incentive rates, promoting a diversified and integrated value chain for medical devices. |
| Focus on Critical Components | Emphasis on manufacturing critical components to foster value chain integration and support the MSME sector. |
Why it Matters
Economic Implications
- Fosters domestic manufacturing and reduces import dependence for critical medical devices, contributing to economic self-reliance.
- Attracts investment in the medical technology sector, leading to capital formation and industrial growth.
- Generates employment opportunities across various skill levels within the manufacturing and allied sectors.
- Aims to reduce the cost of medical devices, making healthcare more affordable and accessible for the populace.
Strategic Importance
- Strengthens India’s healthcare infrastructure by ensuring a stable and indigenous supply of essential medical equipment.
- Enhances India’s global competitiveness in high-end medical technology, positioning the nation as a manufacturing hub.
- Supports the ‘Atmanirbhar Bharat’ and ‘Make in India’ initiatives by promoting local production and value addition.
Social Impact
- Improves the quality of indigenously manufactured medical devices, ensuring better healthcare outcomes.
- Promotes research and development in advanced medical technologies, fostering innovation within the country.
Challenges
1. Technological Gaps
- Bridging the technological gap in manufacturing high-end medical devices that are currently imported or only assembled in India.
- Ensuring access to advanced manufacturing processes and intellectual property for complex medical technologies.
UPSC Link: Science & Technology; Industrial Policy
2. Quality and Standards
- Maintaining international quality standards and regulatory compliance for domestically manufactured medical devices.
- Building trust among healthcare providers and consumers regarding the efficacy and safety of indigenous products.
UPSC Link: Health; Industrial Policy
3. Research and Development
- Fostering a robust ecosystem for R&D to innovate and develop next-generation medical devices.
- Ensuring adequate funding and skilled human resources for sustained innovation.
UPSC Link: Science & Technology; Industrial Policy
4. Supply Chain Integration
- Achieving deep manufacturing and integrating the entire value chain, especially for critical components.
- Addressing potential bottlenecks in the supply of raw materials and specialized components.
UPSC Link: Industrial Policy; Economy
5. Market Access and Competition
- Ensuring fair market access for new domestic manufacturers against established global players.
- Managing competitive pricing while maintaining profitability and quality.
UPSC Link: Economy; Industrial Policy
Challenges — UPSC Perspective
| Issue | Concern |
|---|---|
| High Import Dependence | India heavily relies on imports for advanced medical devices, leading to significant foreign exchange outflow and vulnerability in supply chains. |
| Limited Indigenous R&D | Insufficient investment and infrastructure for research and development hinder the creation of innovative, high-value medical technologies domestically. |
| Quality Perception | Perceptions regarding the quality and reliability of domestically manufactured medical devices sometimes lead to a preference for imported products. |
| Regulatory Harmonization | Aligning domestic regulatory standards with international best practices to ensure global acceptance and export potential of Indian medical devices. |
| Skill Gap | Shortage of skilled workforce in specialized areas like medical device design, engineering, and precision manufacturing. |
Government Initiatives — Must-Memorise for Prelims
- Production Linked Incentive (PLI) Scheme for Medical Devices
Way Forward
- Prioritize investment in research and development to foster innovation and indigenization of high-end medical technologies.
- Establish robust quality control mechanisms and regulatory frameworks to ensure global standards for domestically manufactured devices.
- Promote skill development programs tailored to the medical device manufacturing sector to address the human resource gap.
- Encourage public-private partnerships to leverage expertise and resources for technological advancement and market penetration.
- Facilitate easier access to finance and credit for MSMEs in the medical device sector to boost their manufacturing capabilities.
- Develop a comprehensive ecosystem that supports the entire value chain, from raw material sourcing to post-market surveillance.
- Explore opportunities for international collaboration and technology transfer to accelerate the adoption of advanced manufacturing techniques.
UPSC Value Addition
Keywords for Mains Answer-Writing
Production Linked Incentive Scheme · Medical Devices Sector · Domestic Manufacturing · Ease of Doing Business · Atmanirbhar Bharat · Make in India · Value Chain Integration · High-End Medical Technology · MSME Sector · Healthcare Infrastructure
Concept Flow
Government announces PLI scheme extension and simplification. → New applications invited for medical device manufacturing. → Incentives provided for domestic production across targeted segments. → Increased investment and manufacturing capacity in India. → Reduced import dependence and enhanced self-reliance. → Improved quality and affordability of medical devices.
Prelims Practice Questions
Q1. Consider the following statements regarding the Production Linked Incentive (PLI) Scheme for Medical Devices:
1. The scheme was initiated in the financial year 2021-22.
2. It aims to promote the domestic manufacturing of high-end medical devices and their components.
3. The scheme’s provisions have been simplified, including the removal of minimum sales conditions for incentives.
How many of the above statements are correct?
- Only one
- Only two
- All three
- None
Answer: All three — Statement 1 is correct: The scheme commenced in the financial year 2021-22. Statement 2 is correct: A primary objective is to boost domestic production of advanced medical devices and their critical components. Statement 3 is correct: Recent amendments include simplification of provisions, such as the elimination of minimum sales criteria for incentive eligibility, and reduction in minimum investment requirements.
Q2. Which of the following is NOT a targeted segment under the Production Linked Incentive (PLI) Scheme for Medical Devices, as per the recent amendments?
- Medical consumables, disposables, and implantable devices
- Critical components
- High-end medical devices currently manufactured only through assembly in India
- Traditional Ayurvedic and Unani medical equipment
Answer: Traditional Ayurvedic and Unani medical equipment — The four targeted segments are: TS-1 (Medical consumables, disposables, and implantable devices), TS-2 (Critical components), TS-3 (High-end medical devices with nascent domestic manufacturing), and TS-4 (High-end medical devices currently assembled in India). Traditional Ayurvedic and Unani medical equipment is not listed as a targeted segment under this specific PLI scheme.
Mains Practice Question
✍ The Production Linked Incentive (PLI) Scheme for Medical Devices aims to bolster domestic manufacturing and integrate the value chain. Examine the scheme’s objectives and recent amendments, and discuss its potential impact on India’s healthcare sector and global competitiveness. (15 Marks)
Approach: INTRODUCTION: Briefly introduce the PLI scheme for medical devices and its extension. OBJECTIVES: Detail the core objectives such as promoting domestic manufacturing, attracting investment, creating employment, improving quality, reducing prices, and enhancing global competitiveness, aligning with ‘Atmanirbhar Bharat’ and ‘Make in India’. RECENT AMENDMENTS: Elaborate on the simplified provisions, including the removal of minimum sales conditions, reduction in minimum investment, investor-friendly guidelines, and the continuous application process. TARGET SEGMENTS: Mention the four targeted segments (TS-1 to TS-4) and the focus on value chain integration, especially for critical components and high-end devices. POTENTIAL IMPACT: Discuss the scheme’s likely effects on the healthcare sector (e.g., reduced import dependence, improved access to affordable medical technology, enhanced R&D) and India’s global competitiveness in medical technology. CONCLUSION: Summarise the scheme’s significance in achieving self-reliance and fostering a robust domestic medical device industry.
Source: PIB (Press Information Bureau)
Generated by AanyaAi for educational purpose.
Related guides on our sites
- Best PSIR optional coaching for upsc
- Best PSIR optional teacher for upsc
- Best teacher of PSIR optional for upsc
- Best PSIR optional coaching in delhi for UPSC
- PLI Scheme for Medical Devices: New Applications Invited - November 10, 2026
- जनजातीय गौरव दिवस: रेलवे अधिकारियों द्वारा आदिवासी विरासत का सम्मान - November 10, 2026
- Higher CPI, Fed Rate Hike Hints Impact Global Stock Markets - November 10, 2026
No Comments